Evofem Biosciences EVFM Stock
$0.01
23.076925%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.06M
LOW - HIGH [24H]
$0.01
-
$0.01
VOLUME [24H]
$247.52K
P/E Ratio
0
Earnings per share
-$0.05
ISIN
US30048L3024
Evofem Biosciences Price Chart
Evofem Biosciences EVFM Financial and Trading Overview
| Evofem Biosciences stock price | 0.0080 USD |
| Previous Close | 0.007 USD |
| Open | 0.0068 USD |
| Bid | 0.0071 USD x 18078300 |
| Ask | 0.0072 USD x 1000000 |
| Day's Range | 0.0064 - 0.0071 USD |
| 52 Week Range | 0.001 - 0.02 USD |
| Volume | 265.36K USD |
| Avg. Volume | 196.79K USD |
| Market Cap | 927.71K USD |
| Beta (5Y Monthly) | -1.313 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EVFM Valuation Measures
| Enterprise Value | 56.7M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.012727273 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.045842268 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.802 |
| Enterprise Value/EBITDA | -18.354 |
Trading Information
Evofem Biosciences Stock Price History
| Beta (5Y Monthly) | -1.313 |
| 52-Week Change | -30.00000000000000000000000000000000% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.001 USD |
| 50-Day Moving Average | 0.0079 USD |
| 200-Day Moving Average | 0.009665 USD |
EVFM Share Statistics
| Avg. Volume (3 month) | 196.79K USD |
| Avg. Daily Volume (10-Days) | 178.63K USD |
| Shares Outstanding | 132.53M |
| Float | 132.53M |
| Short Ratio | 0.19 |
| % Held by Insiders | 0.0010% |
| % Held by Institutions | 0% |
| Shares Short | 69.46K |
| Short % of Float | 11.00% |
| Short % of Shares Outstanding | 10.97% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:125 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -29.79% |
| Operating Margin (ttm) | -508.23% |
| Gross Margin | 76.96% |
| EBITDA Margin | -15.26% |
Management Effectiveness
| Return on Assets (ttm) | -21.26% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 20.24M USD |
| Revenue Per Share (ttm) | 0.16 USD |
| Quarterly Revenue Growth (yoy) | 6.40% |
| Gross Profit (ttm) | 15.58M USD |
| EBITDA | -3089000 USD |
| Net Income Avi to Common (ttm) | -6164000 USD |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.62M USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 52.46M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.077 |
| Book Value Per Share (mrq) | -0.586 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -251000 USD |
| Levered Free Cash Flow (ttm) | -1038125 USD |
Profile of Evofem Biosciences
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 7770 Regents Rd |
| ZIP | 92122-1967 |
| Phone | 858 550 1900 |
| Website | https://www.evofem.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29 |
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Q&A For Evofem Biosciences Stock
What is a current EVFM stock price?
Evofem Biosciences EVFM stock price today per share is 0.0080 USD.
How to purchase Evofem Biosciences stock?
You can buy EVFM shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evofem Biosciences?
The stock symbol or ticker of Evofem Biosciences is EVFM.
Which industry does the Evofem Biosciences company belong to?
The Evofem Biosciences industry is Biotechnology.
How many shares does Evofem Biosciences have in circulation?
The max supply of Evofem Biosciences shares is 132.53M.
What is Evofem Biosciences Price to Earnings Ratio (PE Ratio)?
Evofem Biosciences PE Ratio is now.
What was Evofem Biosciences earnings per share over the trailing 12 months (TTM)?
Evofem Biosciences EPS is -0.05 USD over the trailing 12 months.
Which sector does the Evofem Biosciences company belong to?
The Evofem Biosciences sector is Healthcare.
Evofem Biosciences EVFM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Capital Market Composite RCMP | 148.96 USD — |
-1.84
|
— — | 148.23 USD — | 151.02 USD — | — - | — — |
- {{ link.label }} {{link}}